Hypercapnia | Genetic Disorders of Mucociliary Clearance Consortium

Skip to main content

Search

Join Our Contact Registry

RDCRN Alumni badge

Header Social Media

Our Research
Patients and Families
Early Stage Investigators
- Meet Our Early Stage Investigators
News and Events
- Latest News
About Us

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

Elevated carbon dioxide level in the blood leading to increased acid concentrations (acidosis).

Footer menu

Website policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). GDMCC received funding under grant number U54HL096458 as a collaboration between NCATS and the National Heart, Lung, and Blood Institute (NHLBI). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the GDMCC administrative coordinating center at the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH.